U.S. Hot Stocks: Hot Stocks to Watch
July 15 2016 - 9:53AM
Dow Jones News
Among the companies with shares expected to trade actively in
Friday's session are U.S. Bancorp (USB), Herbalife Ltd. (HLF) and
Wells Fargo & Co. (WFC).
U.S. Bancorp said its profit increased in the second quarter as
both loans and deposits rose. Shares rose 1.21% to $41.75 in
premarket trading.
Herbalife Ltd. is to pay $200 million in a settlement with the
Federal Trade Commission that will enable the company to avoid
being classified as a pyramid scheme, a victory in its long-running
battle with activist investor William Ackman. Shares rose 10.68% to
$65.70 premarket.
Wells Fargo & Co. said its second-quarter profit fell as the
nation's third-largest bank by assets continued to deal with low
interest rates that sap lenders' profitability. Shares fell 0.9% to
$48.50 premarket.
Citigroup Inc. (C) on Friday reported better-than-expected
results, despite a 14% year-over-year drop in the bank's profit.
Shares rose 1.12% to $44.95 premarket.
PNC Financial Services Group Inc. (PNC) said its profit fell in
the second quarter amid a decline in revenue, while a key metric of
lending profitability also slipped. Shares rose 1.01% to $83.70
premarket.
Alere Inc. (ALR), which previously disclosed revenue-recognition
issues affecting primarily transactions in Africa and China, said
Thursday it would revise financial results starting in 2013 and
expects to determine that it had material weakness in its internal
controls.
Carmike Cinemas Inc. (CKEC) on Thursday said it was again
pushing back a special meeting of shareholders to take up the
proposed merger with AMC Entertainment Holding Co. (AMC), saying
discussions between the two theater companies continue. Major
Carmike shareholders have criticized AMC's offer as too low and
pointed at AMC's bid for Odeon & UCI Cinemas Group. The meeting
is now slated for July 25.
ConAgra Foods Inc. (CAG) said David Marberger, Prestige Brands
Holdings Inc.'s (PBH) chief financial officer, will take over as
its CFO on Aug. 29 when John Gehring retires.
Ultragenyx Pharmaceutical Inc. (RARE) on Thursday said its
investigational therapy for a rare genetic metabolic disorder met
primary goals in a phase 3 study.
Write to Chris Wack at chris.wack@wsj.com or Maria Armental at
maria.armental@wsj.com
(END) Dow Jones Newswires
July 15, 2016 09:38 ET (13:38 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Herbalife (NYSE:HLF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Herbalife (NYSE:HLF)
Historical Stock Chart
From Sep 2023 to Sep 2024